Nutex Health (NASDAQ:NUTX) Releases Quarterly Earnings Results, Misses Expectations By $3.95 EPS

Nutex Health (NASDAQ:NUTX) released its earnings results on Thursday. The company reported $1.61 EPS for the quarter, missing analysts’ consensus estimates of $5.56 by ($3.95), Zacks reports. Nutex Health had a return on equity of 37.44% and a net margin of 11.62%.The firm had revenue of $151.68 million for the quarter, compared to the consensus estimate of $258.82 million.

Nutex Health Stock Down 12.2%

Nutex Health stock traded down $12.88 during midday trading on Friday, reaching $92.46. The company’s stock had a trading volume of 441,483 shares, compared to its average volume of 199,201. Nutex Health has a 52-week low of $40.67 and a 52-week high of $193.07. The stock’s 50-day simple moving average is $138.40 and its 200-day simple moving average is $124.53. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.20 and a quick ratio of 3.18. The stock has a market capitalization of $653.69 million, a P/E ratio of 5.00 and a beta of 0.03.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on NUTX shares. Wall Street Zen raised Nutex Health from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 28th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Nutex Health in a report on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, Nutex Health currently has an average rating of “Moderate Buy” and a consensus price target of $252.50.

Institutional Trading of Nutex Health

A number of hedge funds have recently added to or reduced their stakes in the company. BNP Paribas Financial Markets boosted its position in shares of Nutex Health by 966.7% in the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after purchasing an additional 290 shares during the period. Royal Bank of Canada boosted its holdings in shares of Nutex Health by 752.4% in the fourth quarter. Royal Bank of Canada now owns 358 shares of the company’s stock valued at $59,000 after acquiring an additional 316 shares during the period. Bank of America Corp DE grew its position in shares of Nutex Health by 6,590.3% during the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after acquiring an additional 2,043 shares during the last quarter. Vestcor Inc purchased a new position in shares of Nutex Health during the third quarter worth approximately $111,000. Finally, Osaic Holdings Inc. increased its holdings in shares of Nutex Health by 280.3% in the 4th quarter. Osaic Holdings Inc. now owns 810 shares of the company’s stock valued at $133,000 after acquiring an additional 597 shares during the period. 5.32% of the stock is owned by hedge funds and other institutional investors.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.